Trial intelligence / Profile preview

PRF vs TRF for Thoracic Metastatic Pain

NCT03204942Completed

Sponsor
National Cancer Institute
Start
Feb 2017
Primary completion
Jul 2018
Countries
1
01

Overview

Randomised, single-blind trial (3 arms), sponsored by National Cancer Institute. Primary endpoints: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 at 3 months, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases 22 at 3 months and 2 more. Started Feb 2017; status: completed.

Beyond the preview

Go deeper on NCT03204942.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03204942.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call